KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Non-Current Liabilities (2016 - 2025)

AbbVie (ABBV) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $104.7 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 2.94% to $104.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $104.7 billion through Dec 2025, up 2.94% year-over-year, with the annual reading at $104.7 billion for FY2025, 2.94% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $104.7 billion at AbbVie, roughly flat from $104.9 billion in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $124.2 billion in Q1 2021, with the low at $101.7 billion in Q4 2024.
  • Average Total Non-Current Liabilities over 5 years is $110.5 billion, with a median of $108.1 billion recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 36.15% in 2021, then fell 14.22% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $116.2 billion in 2021, then dropped by 9.53% to $105.1 billion in 2022, then fell by 0.68% to $104.4 billion in 2023, then fell by 2.64% to $101.7 billion in 2024, then increased by 2.94% to $104.7 billion in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $104.7 billion, $104.9 billion, and $105.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.